APDN just had another volume surge on no news.
I think you are overestimating their need for financing, they have enough cash now to cover their burn rate for the next year.
The CEO also said at least one of their 14+ pharmaceutical company prospects is close to signing a licensing agreement with an up front retainer and milestone payments for their LineaRx division to produce DNA for pre-clinical development programs.
I also like the potential for their iCTC platform to be developed into a new cancer testing platform, given the results Tyme has published about earlier detection and more accurate correlation to actual cancer development than the standard antibody tests.
"Our houses are such unwieldy property that we are often imprisoned rather than housed in them." - Henry David Thoreau, Walden: Economy, 1854